U.S. flag

An official website of the United States government

NM_007059.4(KPTN):c.102C>T (p.Gly34=) AND Macrocephaly-developmental delay syndrome

Germline classification:
Conflicting classifications of pathogenicity (2 submissions)
Last evaluated:
Sep 20, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001204463.11

Allele description [Variation Report for NM_007059.4(KPTN):c.102C>T (p.Gly34=)]

NM_007059.4(KPTN):c.102C>T (p.Gly34=)

Gene:
KPTN:kaptin, actin binding protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.32
Genomic location:
Preferred name:
NM_007059.4(KPTN):c.102C>T (p.Gly34=)
HGVS:
  • NC_000019.10:g.47484059G>A
  • NG_034097.1:g.5206C>T
  • NM_001291296.2:c.102C>T
  • NM_007059.4:c.102C>TMANE SELECT
  • NP_001278225.1:p.Gly34=
  • NP_008990.2:p.Gly34=
  • NC_000019.9:g.47987316G>A
  • NM_007059.3:c.102C>T
  • NR_111923.2:n.161C>T
Links:
dbSNP: rs377099246
NCBI 1000 Genomes Browser:
rs377099246
Molecular consequence:
  • NR_111923.2:n.161C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001291296.2:c.102C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_007059.4:c.102C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Macrocephaly-developmental delay syndrome (MRT41)
Synonyms:
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 41
Identifiers:
MONDO: MONDO:0014289; MedGen: C3810225; Orphanet: 397612; OMIM: 615637

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001375669Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 7, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV0053287273billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Sep 20, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001375669.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with KPTN-related conditions. This variant is present in population databases (rs377099246, ExAC 0.02%). This sequence change affects codon 34 of the KPTN mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the KPTN protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV005328727.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 19, 2025